Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-Pharmaceuticals-S-p-A-Announces-Paragraph-IV-ANDA-Filing-for-Xadago-safinamide-in-the-U-33151104/?utm_source=whatsapp&utm_medium=social&utm_campaign=share